Defect of Articular Cartilage
1
Pipeline Programs
3
Companies
3
Clinical Trials
0
Approved Products
Pipeline by Development Stage
Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
1
0
0
0
Early DiscoveryClinical DevelopmentMarket
Competitive Landscape
3 companies ranked by most advanced pipeline stage
ArthrexCA - Santa Barbara
1 programComparison of BioCartilage Versus Marrow Stimulating Procedure for Cartilage Defects of the KneeN/A1 trial
Active Trials
Trial Timeline
Clinical trial activity over time
2021
2022
2023
2024
2025
2026
AbelZeta PharmaReJoinTM
Anika TherapeuticsHyalofast
ArthrexComparison of BioCartilage Versus Marrow Stimulating Procedure for Cartilage Defects of the Knee
Clinical Trials (3)
Total enrollment: 253 patients across 3 trials
Clinical Trial to Compare ReJoinTM to Sodium Hyaluronate Injection for Knee Osteoarthritis Cartilage Defects
Start: Jul 2014Est. completion: Dec 201928 patients
Phase 2Unknown
HyaloFAST Trial for Repair of Articular Cartilage in the Knee
Start: Dec 2015Est. completion: Jun 2026200 patients
N/AActive Not Recruiting
NCT02203071ArthrexComparison of BioCartilage Versus Marrow Stimulating Procedure for Cartilage Defects of the Knee
Comparison of BioCartilage Versus Marrow Stimulating Procedure for Cartilage Defects of the Knee
Start: Jun 2014Est. completion: Sep 201825 patients
N/ACompleted
Phase Legend
Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available
Key Insights
3 companies competing in this space
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.